The Patients’ Access to Treatments Act of 2012 (H.R. 4209), introduced this past March, is a critical piece of legislation that, if adopted, would improve patient access to “speciality” medications. The bill proposes limited co-payment, co-insurance and other cost-sharing requirements implemented by insurance plans for expensive drugs in specialty tiers. Currently, these plans can require patients to pay up to 25% to 33% of the drug cost, placing an enormous burden on those with chronic, disabling or life-threatening conditions.
The COPD Foundation, Alpha-1 Foundation and Alpha-1 Association strongly support the bill, and encourage you to write your lawmakers to serve as co-sponsors! Feel free to personalize the provided template letter and add your own unique story.